Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

This article has been Reviewed by the following groups

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Abstract

The rising case numbers of the SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 subvariants has generated serious concern about the course of the pandemic. Here we examine the neutralization resistance, infectivity, processing, and fusogenicity of spike from the BA.4/5 and BA.2.12.1 SARS-CoV-2 variants compared with other Omicron subvariants and Delta. Critically, we found that the new Omicron subvariants BA.4/5 and BA.2.12.1 were more resistant to neutralization by mRNA-vaccinated and boosted health care worker sera and Omicron-BA.1-wave patient sera than were the BA.1 and BA.2 variants. Interestingly, Delta-wave patient sera neutralized more efficiently against not only Delta but also BA.4/5 and BA.2.12.1 variants that also contain substitutions at position L452, similar to Delta. The BA.4/5 and BA.2.12.1 variants also exhibited higher fusogenicity, and increased spike processing, dependent on the L452 substitution. These results highlight the key role of the L452R and L452Q mutations in BA.4/5 and BA.2.12.1 subvariants.

Article activity feed

  1. SciScore for 10.1101/2022.05.16.492158: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    EthicsConsent: Demographic information was self-reported, and all subjects provided informed consent.
    Sex as a biological variableSera were collected 3-4 weeks post-second vaccine dose for 15 HCWs (7 female and 8 male; median age 37; age range 31-56), which included 4 Moderna mRNA-1273 and 11 Pfizer/BioNTech BNT162b2 vaccinated HCWs.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Once dissociated, cells were fixed in 4% formaldehyde diluted in 1X PBS and stained with primary antibody anti-S1 (Sino Biological, 40150-T62).
    anti-S1
    suggested: None
    Cells were then stained with secondary antibody anti-rabbit-IgG-FITC (Sigma, F9887) and processed by a Life Technologies Attune NxT flow cytometer.
    anti-rabbit-IgG-FITC
    suggested: None
    Membranes were blotted with anti-S1 (Sino Biological, 40150-T62), anti-p24 (Abcam, ab63917; NIH ARP-1513), and anti-GAPDH (Santa Cruz Biotech, sc-47724).
    anti-GAPDH
    suggested: (Santa Cruz Biotechnology Cat# sc-47724, RRID:AB_627678)
    Anti-mouse-IgG-Peroxidase (Sigma, A5278) and anti-rabbit-IgG-HRP (Sigma, A9169) were used as secondary antibodies accordingly.
    Anti-mouse-IgG-Peroxidase
    suggested: None
    anti-rabbit-IgG-HRP
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    HEK293T (ATCC CRL-11268, RRID: CVCL_1926) and HEK293T-ACE2 (BEI NR-52511, RRID: CVCL_A7UK) cells were maintained in DMEM (Gibco, 11965-092) supplemented with 10% FBS (Sigma, F1051) and 1% penicillin-streptomycin (HyClone, SV30010).
    HEK293T
    detected: (ATCC Cat# CRL-11268, RRID:CVCL_1926)
    HEK293T-ACE2
    detected: ( RRID:CVCL_A7UK)
    CaLu-3 cells (RRID: CVCL_0609) were maintained in EMEM (ATCC 30-2003) supplemented with 10% FBS and 1% penicillin-streptomycin.
    CaLu-3
    detected: (ATCC Cat# HTB-55, RRID:CVCL_0609)
    pNL4-3-inGluc and spike constructs were transfected into HEK-293T cells in a 2:1 ration using polyethylenimine transfection.
    HEK-293T
    suggested: None
    Pseudotyped virus for each SARS-CoV-2 spike, produced in parallel, were used to infect target HEK293T-ACE2 or CaLu-3 cells.
    CaLu-3
    suggested: KCLB Cat# 30055, RRID:CVCL_0609)
    Virus and serum were incubated for 1 hr at 37°C and then added to HEK293T-ACE2 cells for infection by neutralized virus.
    HEK293T-ACE2
    suggested: None
    Spike detection by flow cytometry: HEK293T cells used to produce pseudotyped vectors were harvested and fixed 72 hrs after transfection.
    HEK293T
    suggested: None
    Recombinant DNA
    SentencesResources
    GenScript Biotech (Piscataway, NJ) produced and cloned SARS-CoV-2 spike constructs with N- and C-terminal flag tags using Kpn I and BamH I restriction enzyme cloning into a pcDNA3.1 vector.
    pcDNA3.1
    suggested: RRID:Addgene_79663)
    pNL4-3-inGluc and spike constructs were transfected into HEK-293T cells in a 2:1 ration using polyethylenimine transfection.
    pNL4-3-inGluc
    suggested: None
    Software and Algorithms
    SentencesResources
    NT50 values were determined by least-squares-fit, non-linear regression in GraphPad Prism 9 (San Diego, CA).
    GraphPad
    suggested: (GraphPad Prism, RRID:SCR_002798)
    Results were analyzed using FlowJo v7.6.5 (Ashland, OR).
    FlowJo
    suggested: (FlowJo, RRID:SCR_008520)
    NT50 values were determined by least-squares fit non-linear regression in GraphPad Prism 9.
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)
    Western Blot quantification was performed using NIH ImageJ and by setting the ratio of S1/S and S1/p24 of BA.2 to 1.00.
    ImageJ
    suggested: (ImageJ, RRID:SCR_003070)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.